AGARWAL SUNIL
CIK: 0001616640•EVP, Head of Development & CMO
Officer
Primary company: Ultragenyx Pharmaceutical Inc. (RARE)
AGARWAL SUNIL is a corporate insider (EVP, Head of Development & CMO) at Ultragenyx Pharmaceutical Inc. (RARE) filing SEC Form 4 transactions. 88 transactions across 7 companies, totaling $0 in purchases and $4,279,698 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
ARVINAS, INC. ARVN | Award | 23,105 | - | - | 23,105 | 6/25/2025 Filed: 6/30/2025 | Filing → |
ARVINAS, INC. ARVN | Award | 16,025 | - | - | 30,166 | 6/25/2025 Filed: 6/30/2025 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 26,550 | - | - | 26,550 | 6/11/2025 Filed: 6/12/2025 | Filing → |
ARVINAS, INC. ARVN | Award | 9,070 | - | - | 9,070 | 5/29/2024 Filed: 5/31/2024 | Filing → |
ARVINAS, INC. ARVN | Award | 5,899 | - | - | 14,141 | 5/29/2024 Filed: 5/31/2024 | Filing → |
Astria Therapeutics, Inc. ATXS | Award | 28,200 | - | - | 28,200 | 4/8/2024 Filed: 4/9/2024 | Filing → |
ARVINAS, INC. ARVN | Award | 24,948 | $0.00 | $0 | 24,948 | 6/15/2023 Filed: 6/20/2023 | Filing → |
ARVINAS, INC. ARVN | Award | 8,242 | $0.00 | $0 | 8,242 | 6/15/2023 Filed: 6/20/2023 | Filing → |
| Award | 20,000 | $0.00 | $0 | 20,000 | 6/1/2022 Filed: 6/3/2022 | Filing → | |
| Award | 250,000 | $0.00 | $0 | 250,000 | 3/3/2022 Filed: 3/8/2022 | Filing → | |
| Sale | 1,627 | $26.00 | $42K | 1,550,000 | 9/16/2021 Filed: 9/17/2021 | Filing → | |
| Sale | 58,373 | $26.07 | $1.52M | 1,551,627 | 9/15/2021 Filed: 9/17/2021 | Filing → | |
| Award | 20,000 | $0.00 | $0 | 20,000 | 6/11/2021 Filed: 6/14/2021 | Filing → | |
| Award | 76,682 | $0.00 | $0 | 76,682 | 2/3/2021 Filed: 2/18/2021 | Filing → | |
| Award | 48,000 | $0.00 | $0 | 48,000 | 2/3/2021 Filed: 2/5/2021 | Filing → | |
MyoKardia, Inc. MYOK | Disposition | 3,000 | - | - | 0 | 11/17/2020 Filed: 11/19/2020 | Filing → |
MyoKardia, Inc. MYOK | Disposition | 6,600 | - | - | 0 | 11/17/2020 Filed: 11/19/2020 | Filing → |
MyoKardia, Inc. MYOK | Disposition | 11,000 | - | - | 0 | 11/17/2020 Filed: 11/19/2020 | Filing → |
MyoKardia, Inc. MYOK | Disposition | 11,000 | - | - | 0 | 11/17/2020 Filed: 11/19/2020 | Filing → |
MyoKardia, Inc. MYOK | Disposition | 11,000 | - | - | 0 | 11/17/2020 Filed: 11/19/2020 | Filing → |
ARVINAS, INC.
ARVN
Type
Award
Shares
23,105
Price
-
Value
-
ARVINAS, INC.
ARVN
Type
Award
Shares
16,025
Price
-
Value
-
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
26,550
Price
-
Value
-
ARVINAS, INC.
ARVN
Type
Award
Shares
9,070
Price
-
Value
-
ARVINAS, INC.
ARVN
Type
Award
Shares
5,899
Price
-
Value
-
Astria Therapeutics, Inc.
ATXS
Type
Award
Shares
28,200
Price
-
Value
-
ARVINAS, INC.
ARVN
Type
Award
Shares
24,948
Price
$0.00
Value
$0
ARVINAS, INC.
ARVN
Type
Award
Shares
8,242
Price
$0.00
Value
$0
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Type
Award
Shares
250,000
Price
$0.00
Value
$0
Type
Sale
Shares
1,627
Price
$26.00
Value
$42K
Type
Sale
Shares
58,373
Price
$26.07
Value
$1.52M
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Type
Award
Shares
76,682
Price
$0.00
Value
$0
Type
Award
Shares
48,000
Price
$0.00
Value
$0
MyoKardia, Inc.
MYOK
Type
Disposition
Shares
3,000
Price
-
Value
-
MyoKardia, Inc.
MYOK
Type
Disposition
Shares
6,600
Price
-
Value
-
MyoKardia, Inc.
MYOK
Type
Disposition
Shares
11,000
Price
-
Value
-
MyoKardia, Inc.
MYOK
Type
Disposition
Shares
11,000
Price
-
Value
-
MyoKardia, Inc.
MYOK
Type
Disposition
Shares
11,000
Price
-
Value
-
AI Agent
Try asking...